Found 12 matching trials
SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients
PHASE2Open label multicentric randomized phase II trial, using high throughput ge...
Location
Centre Hospitalier Henri Duffau
Healthy Volunteers, Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] AZD8931
PHASE1Study to Assess the Absorption, Metabolism and Excretion of \[14C\]AZD8931 ...
Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment
PHASE1To compare the activity of AZD8931 against placebo on the cell markers in c...
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
PHASE2The main purpose of this study is to compare progression free survival in p...
Study of AZD8931 in Patients With Advanced Solid Malignancies
PHASE1The main purpose of this study is to explore the safety and tolerability of...
Phase I/II Trial of Antagonism of HER in GI Cancer
PHASE2Recruitment to phase I of the PANTHER trial is complete.
Phase II, is to e...
Location
Barts Health NHS Trust
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
PHASE2Open label multicentric phase II randomized trial, using high throughput ge...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer
PHASE2The purpose of the study is to assess the efficacy and safety and PK of AZD...
A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and Females
PHASE1A study to compare two different tablet formulations of AZD8931 in healthy ...
A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets
PHASE1Phase I, randomised, open label, 3-period crossover study in healthy male s...